Four international teams awarded £4.7m to investigate heart and circulatory diseases
These types of conditions are responsible for 25% of all UK deaths and affect 7.6 million people nationally
Read More
Tag: German Centre for Cardiovascular Research
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
